Acorda Therapeutics, Inc.
11
David S Jones
04/01/2024
11/22/2024
Yes
v
| CLMAGT, MEGA, MEGANY, Lead |
Assigned to: Judge David S Jones Chapter 11 Voluntary Asset |
|
Debtor Acorda Therapeutics, Inc.
2 Blue Hill Plaza, 3rd Floor Pearl River, NY 10965 ROCKLAND-NY Tax ID / EIN: 13-3831168 |
represented by |
Blaire Cahn
Baker & McKenzie LLP 452 Fifth Avenue New York New York, NY 10018 212-626-4695 Email: blaire.cahn@bakermckenzie.com John R. Dodd
Baker McKenzie LLP 1111 Brickell Avenue Suite 1700 Miami, FL 33131 305-789-8900 Email: john.dodd@bakermckenzie.com Courtney E Giles
Baker & McKenzie 800 Capitol Street Ste 2100 Houston, TX 77002 713-427-5086 Fax : 713-427-5099 Email: courtney.giles@bakermckenzie.com Kyle J. Ortiz
Togut, Segal & Segal LLP One Penn Plaza Suite 3335 New York, NY 10119 212-594-5000 Fax : 212-967-4258 Email: kortiz@teamtogut.com L Andrew S Riccio
Baker & McKenzie LLP 452 Fifth Avenue New York, NY 10018 212-626-4229 Email: andrew.riccio@bakermckenzie.com Annasofia Alexandra Roig
Baker McKenzie LLP 1111 Brickell Avenue 10th Floor Miami, FL 33131 205-789-8900 Fax : 305-789-8953 Email: roiga@flcourts.org |
U.S. Trustee United States Trustee
Office of the United States Trustee - NY Alexander Hamilton Custom House One Bowling Green, Room 534 New York, NY 10004-1408 (212) 510-0500 |
represented by |
Brian S. Masumoto
DOJ-Ust Alexander Hamilton Custom House One Bowling Green Room 534 New York, NY 10004-1408 212-510-0500 Email: nysbnotice@gmail.com Tara Tiantian
DOJ-Ust Alexander Hamilton Custom House One Bowling Green, Room 534 New York, NY 10004 212-510-0500 Email: tara.tiantian@usdoj.gov |
Claims and Noticing Agent Kroll Restructuring Administration LLC Claims Agent
(Formerly Prime Clerk LLC) 55 East 52nd Street 17th Floor www.kroll.com New York, NY 10055 (212) 257-5450 |
| |
Creditor Committee The Official Committee of Unsecured Creditors |
represented by |
Darren T. Azman
McDermott Will & Emery One Vanderbilt Avenue New York, NY 10017 212-547-5615 Fax : 212-547-5444 Email: dazman@mwe.com Kristin K. Going
McDermott Will & Emery One Vanderbilt Avenue New York, NY 10017 212-547-5429 Fax : 212-547-5444 Email: kgoing@mwe.com |
| Date Filed | # | Docket Text |
|---|---|---|
| 07/12/2024 | 373 | Notice of Certification of Publication of Justin Lewenson Regarding Amended Notice of (I) Hearing on Confirmation of the Plan and Procedures for Objecting to Confirmation of the Plan; and (II) Procedures and Deadline for Voting on the Plan (related document(s)358) filed by Kroll Restructuring Administration LLC.(Steele, Benjamin) (Entered: 07/12/2024) |
| 07/11/2024 | 372 | Agreed Confidentiality Agreement and Protective Order Signed on 7/11/2024. (Calderon, Lynda) (Entered: 07/11/2024) |
| 07/11/2024 | 371 | Affidavit of Service of Ali Hamza Regarding First Amended Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc. and Its Affiliated Debtors, First Amended Disclosure Statement for Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc. and Its Affiliated Debtors, Notice of Filing Blacklined Solicitation Version of the First Amended Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc. and Its Affiliated Debtors, and Notice of Filing Blacklined Solicitation Version of the First Amended Disclosure Statement for Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc. and Its Affiliated Debtors (related document(s)352, 354, 351, 353) filed by Kroll Restructuring Administration LLC Claims Agent.(Malo, David) (Entered: 07/11/2024) |
| 07/10/2024 | 370 | Affidavit of Service of Melissa Diaz Regarding Notice of Third Extension of Milestones in RSA and DIP Financing (related document(s)341) filed by Kroll Restructuring Administration LLC Claims Agent.(Malo, David) (Entered: 07/10/2024) |
| 07/10/2024 | 369 | Statement / Notice Regarding the Assumption and Assignment of Certain Government Contracts (related document(s)303, 109) filed by John R. Dodd on behalf of Acorda Therapeutics, Inc.. (Dodd, John) (Entered: 07/10/2024) |
| 07/10/2024 | 368 | Affidavit of Service of Engels Medina Regarding First Amended Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc. and its Affiliated Debtors, Notice of Filing Blacklined First Amended Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc., and its Affiliated Debtors, First Amended Disclosure Statement for Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc. And its Affiliated Debtors, Notice of Filing Blacklined First Amended Disclosure Statement for Joint Chapter 11 Plan of Liquidation of Acorda Therapeutics, Inc., and its Affiliated Debtors, and Notice of Filing Revised Proposed Order (I) Approving the Disclosure Statement; (II) Establishing Notice and Objection Procedures for Confirmation of the Plan; (III) Approving Notice Packages and Procedures for Distribution Thereof; (IV) Approving the Forms of Ballots and Establishing Procedures for Voting on the Plan; and (V) Granting Related Relief (related document(s)346, 348, 347, 349, 350) filed by Kroll Restructuring Administration LLC Claims Agent.(Malo, David) (Entered: 07/10/2024) |
| 07/10/2024 | 367 | Statement / Notice Regarding the Assumption and Assignment of Caremark/CVS Agreements (related document(s)303, 109) filed by John R. Dodd on behalf of Acorda Therapeutics, Inc.. (Dodd, John) (Entered: 07/10/2024) |
| 07/09/2024 | 366 | Affidavit of Service of Jonathan Ruvinov Regarding Notice of Agenda of Matters Scheduled for Hearing on July 2, 2024, at 11:00 a.m. (Prevailing Eastern Time), and Notice of Presentment (related document(s)345, 344) filed by Kroll Restructuring Administration LLC.(Malo, David) (Entered: 07/09/2024) |
| 07/09/2024 | 365 | Affidavit of Service of Amy Castillo Regarding Declaration and Disclosure Statement of Daniel T. Moss on Behalf of Jones Day (related document(s)343) filed by Kroll Restructuring Administration LLC.(Malo, David) (Entered: 07/09/2024) |
| 07/08/2024 | 364 | Statement / Notice of Second Extension of Challenge Period Pursuant to Final Order (I) Authorizing Debtors to Obtain Postpetition Financing Pursuant to Section 364 of the Bankruptcy Code, (II) Authorizing the Use of Cash Collateral Pursuant to Section 363 of the Bankruptcy Code, (III) Granting Adequate Protection to the Prepetition Secured Parties Pursuant to Sections 361, 362, 363, and 364 of the Bankruptcy Code, (IV) Granting Liens and Superpriority Claims, (V) Modifying the Automatic Stay, and (VI) Granting Related Relief (related document(s)129) filed by John R. Dodd on behalf of Acorda Therapeutics, Inc.. (Dodd, John) (Entered: 07/08/2024) |